Fusion Antibodies announced on Friday that its OptiMAL validation project with the US National Cancer Institute (NCI) was progressing as planned.
Metals One announced on Friday that it has completed a preliminary economic assessment (PEA) for its Finland Black Schist Ni-Cu-Co-Zn Project, identifying the Rautavaara (R1) deposit as the key economic driver.
Celadon Pharmaceuticals reported on Friday that it has received £0. 897m of a £1m drawdown request from its committed credit facility, with the remaining £0. 1m now expected in February.
Prospex Energy reported a significant increase in production and revenue from the Selva Malvezzi production concession in Italy on Friday, with gross revenue for the fourth quarter reaching €3. 38m, a 91% rise compared to the final three months of 2023.
Cohort announced the completed acquisition of EM Solutions on Friday, following earlier announcements in November and January.
Faron Pharmaceuticals announced on Friday that it has identified the final patient for its BEXMAB phase two dose optimisation study in refractory or relapsed myelodysplastic syndrome (r/r MDS) and its phase one and two study in frontline high-risk (HR) MDS.
Reabold Resources announced on Friday that it has completed the acquisition of additional shares in Rathlin Energy UK from Connaught Oil & Gas for £0. 7m, increasing its equity interest in Rathlin to about 79. 8%.
Gemfields reported total auction revenue of $196m for 2024 on Friday, as it continued to invest in the expansion of its Montepuez Ruby Mine (MRM) in Mozambique.
Focusrite said in an update on Friday that trading for the first half of its financial year was expected to align with the board’s expectations, with performance anticipated to be weighted towards the second half as channel destocking in the US eased.
International healthcare firm Alliance Pharma said on Friday that FY24 group profits would be in line with expectations despite a modest downturn in revenues.
Defence products manufacturer Avon Technologies said on Friday that Q1 trading was in line with expectations and that its outlook for the FY remained consistent with previous guidance.
The Property Franchise Group reported a transformational 2024 on Thursday, with revenue rising 146% to £67. 2m, driven by organic growth and the acquisitions of Belvoir Group and GPEA.
Concrete slab measurement and installation equipment specialist Somero Enterprises reported 2024 full-year revenue of $109. 2m in an update on Thursday, in line with guidance and market expectations.
Fintel reported a strong full-year financial and strategic performance in an update on Thursday, with revenue increasing 21% to £78. 3m, driven by organic growth and acquisitions.
MaxCyte announced on Thursday that it has acquired SeQure Dx, a specialist in on-target and off-target editing assessment services for cell and gene therapies, in a move aimed at broadening its offerings in the cell engineering space.
Mulberry Group laid out turnaround plans on Thursday, including halting losses and reclaiming its position as a must-have, iconic British brand.
Marketing business Next 15 warned on Thursday that profits for the twelve months ending 31 January would be at the bottom end of expectations despite "an encouraging uptick" in new business wins in the latter half of the year.
Novacyt reported strong revenue growth for 2024 in an update on Thursday, with unaudited statutory revenue reaching about £19. 6m, an 85% increase from the prior year's £10. 6m.
Oil and gas exploration firm Tullow Oil said on Thursday that it was exploring a potential sale of its non-core assets as part of an effort to bring its debt below $1. 0bn.
Natural extracts and ingredients business Treatt said on Thursday that Q1 revenues were in line with internal expectations and that Q2 had "started well".